Human pharmaceuticals in Portuguese rivers: The impact of water scarcity in the environmental risk (original) (raw)
Related papers
Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers
The Science of the total environment, 2015
A multitude of pharmaceuticals enter surface waters via discharges of wastewater treatment plants (WWTPs), and many raise environmental and health concerns. Chemical fate models predict their concentrations using estimates of mass loading, dilution and in-stream attenuation. However, current comprehension of the attenuation rates remains a limiting factor for predictive models. We assessed in-stream attenuation of 75 pharmaceuticals in 4 river segments, aiming to characterize in-stream attenuation variability among different pharmaceutical compounds, as well as among river segments differing in environmental conditions. Our study revealed that in-stream attenuation was highly variable among pharmaceuticals and river segments and that none of the considered pharmaceutical physicochemical and molecular properties proved to be relevant in determining the mean attenuation rates. Instead, the octanol-water partition coefficient (Kow) influenced the variability of rates among river segmen...
The Science of the total environment, 2015
Considerable amounts of pharmaceuticals are used in human and veterinary medicine, which are not efficiently removed during wastewater and slurries treatment and subsequently entering continuously into freshwater systems. The intrinsic biological activity of these non-regulated pollutants turns their presence in the aquatic environment into an ecological matter of concern. We present the first quantitative study relating the presence of pharmaceuticals and their predicted ecotoxicological effects with human population and livestock units. Four representative Iberian River basins (Spain) were studied: Llobregat, Ebro, Júcar and Guadalquivir. The levels of pharmaceuticals were determined in surface water and sediment samples collected from 77 locations along their stream networks. Predicted total toxic units to algae, Daphnia and fish were estimated for pharmaceuticals detected in surface waters. The use of chemometrics enabled the study of pharmaceuticals for: their spatial distribut...
Pharmaceutical pollution of the world’s rivers
Proceedings of the National Academy of Sciences, 2022
Environmental exposure to active pharmaceutical ingredients (APIs) can have negative effects on the health of ecosystems and humans. While numerous studies have monitored APIs in rivers, these employ different analytical methods, measure different APIs, and have ignored many of the countries of the world. This makes it difficult to quantify the scale of the problem from a global perspective. Furthermore, comparison of the existing data, generated for different studies/regions/continents, is challenging due to the vast differences between the analytical methodologies employed. Here, we present a global-scale study of API pollution in 258 of the world’s rivers, representing the environmental influence of 471.4 million people across 137 geographic regions. Samples were obtained from 1,052 locations in 104 countries (representing all continents and 36 countries not previously studied for API contamination) and analyzed for 61 APIs. Highest cumulative API concentrations were observed in ...
Pollution by psychoactive pharmaceuticals in the Rivers of Madrid metropolitan area (Spain
Environment International, 2010
There are a number of reports in the literature which describe the occurrence of so-called emerging pollutants, such as pharmaceuticals, in surface water. Few of these studies have reported values from large cities in relatively arid areas, such as in Spain. The persistence of some pharmaceuticals to usual wastewater treatments allows their discharge into surface waters. It is increasingly evident that mental health problems are of special concern for public health since psychiatric drugs are used in large amounts. Compared to other countries, Spain has a high pharmaceutical consumption rate, and Madrid metropolitan area is one of the most densely populated areas in Europe. The aim of the present study was to determine the presence of different psychoactive pharmaceuticals and metabolites in the main rivers of Madrid metropolitan area: Jarama, Manzanares, Guadarrama, Henares and Tajo. Sampling was done downstream of ten sewage treatment plants (STP) discharging into these rivers. Control points upstream of STPs discharge points were also sampled. Pharmaceutical compounds and metabolites for analysis were selected according to human consumption and prescription rates in Madrid, and the availability of valid techniques for detection. We observed residues of the antidepressants fluoxetine (80% of the sampling sites), citalopram (60%) and venlafaxine (100%), the anxiolytics nordiazepam (90%), oxazepam (80%) and 7-aminoflunitrazepam (10%) and the anticonvulsant carabamazepine (70%). Measured concentrations equalled or exceeded those reported for other geographical areas, although there is a pronounced lack of information for the anxiolytics and venlafaxine. This is of special concern given that Wyeth–Ayerst's venlafaxine, Effexor, was the 10th greatest selling pharmaceutical worldwide in 2006. We conclude that the origin of pharmaceutical pollution in the rivers of Madrid is mainly the discharge of sewage treatment plants in Madrid's metropolitan area and a comprehensive monitoring program should be implemented.